Bayzed Health Group Inc (02609) reported that its authorized share capital remained at 5,000,000,000 ordinary shares, each with a par value of US$0.00001, totaling US$50,000 as of January 31, 2026. The number of issued shares stood at 1,318,466,823, reflecting no change from the previous month.

No treasury shares were recorded, and no additional share issuance or share repurchase transactions took place. The company confirmed compliance with applicable public float requirements. No exercise of share options or convertible securities occurred during the reporting period, and no new agreements or arrangements were noted for the issue of additional shares.